CM
CME Group Inc.
CME · NASDAQ
$281.29 +0.64% (+$1.79)
1M +6.69%
Market Cap $101.1B
P/E Ratio 23.68x
Div. Yield 4.00%
ROE 15.53%
Bulios Fair Price
$237.32
15.6% downside
Current Price
$281.29
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CME is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
13 /100
Expensive P/S 14.93x
P/B 3.81x
P/E 23.68x
Growth
67 /100
Growing Rev. growth 9.11%
Book val. growth 2.24%
EPS growth 14.68%
Profitability
100 /100
Strong Op. margin 65.10%
Net margin 63.08%
FCF margin N/A
Quality
91 /100
Excellent ROA 2.19%
Asset turnover 0.03x
ROE 15.53%
Debt
77 /100
Low Current ratio 1.02x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
75 /100
Stable Rev. volatility 2.47%
EPS volatility 5.32%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CME
Online
Sector
Financial Services
Industry
Financial - Data & Stock Exchanges
CEO
Terrence A. Duffy
Employees
3,875
Headquarters
Chicago
Upcoming events
09 SEP
Ex-Dividend
Ex-dividend date
25 SEP
Dividend Payment
Payment date
28 OCT
Earnings
Upcoming earnings report